Fierce Pharma
JULY 20, 2023
Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. | Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. A group of lawmakers is working to change that.
Pharma Marketing Network
JULY 19, 2023
Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
JULY 17, 2023
During the 2023 Condé Nast Health Upfront , a virtual event that was held on June 27, the media company revealed several new offerings for advertisers that meet the needs of growing industry trends around influencer marketing, video, authentic engagement, and culture as the newest health KPI. In terms of influencer marketing, Condé Nast announced Allure’s Creators Network and the SELF Care Squad, which will allow advertisers to tap into influential voices in health and align with these carefully
MedCity News
JULY 20, 2023
Nurse unions and labor experts agree that the pandemic was a turning point that catalyzed nurses to fight for improved working conditions and overall better treatment from their employers. By negotiating new contracts with their employers, unions are working hard to both uphold patient safety and mitigate the nursing field’s debilitating workforce shortage.
Fierce Pharma
JULY 19, 2023
After Novo Nordisk's popular obesity medicine Wegovy went into short supply, people turned to the company first-generation weight-loss drug, Saxenda, for treatment. | After Novo Nordisk's Wegovy became hard to come by, people turned to the company first-generation weight loss drug, Saxenda, for treatment. Now, the company is struggling to handle demand for that product.
Pharma Marketing Network
JULY 19, 2023
Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. By creating and distributing valuable content, businesses can attract and engage their target audience, position themselves as experts in their field, and build trust with potential customers.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JULY 18, 2023
More than half of employees said they don’t have mental health benefits in their benefit package or aren’t sure if they do, according to a new survey. About two-thirds of respondents said they would use a digital mental health benefit if it was offered to them.
Fierce Pharma
JULY 17, 2023
Sanofi’s immunization scheme is starting to fall into place thanks to an approval that could propel it and its partner AstraZeneca to the front lines of the respiratory syncytial virus (RSV) scene. | Sanofi’s immunization scheme is starting to fall into place thanks to an approval that could propel it and its partner AstraZeneca to the front lines of the RSV scene.
Pharma Marketing Network
JULY 19, 2023
Sponsorships can be a powerful way for businesses to connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But in order to be truly effective, sponsorships must be aligned with a company’s brand values. For pharmaceutical companies, this means aligning sponsorships with causes that are related to health and wellness.
PM360
JULY 18, 2023
Digital Health Networks , a global leader in healthcare-focused original content production and OTT streaming, announced the list of judges for the inaugural CINEHEALTH International Film and Video Festival where “The CINEHEALTH Awards” will be presented in the following categories: Feature Films, TV episodic series, short-form videos, social media, and TikTok reels.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
JULY 21, 2023
What we need to overcome adherence challenges is a digitally enabled marketplace of options that can be personalized to the patient and the context of their specific condition, pharmacy preference and ability to pay.
Fierce Pharma
JULY 17, 2023
From its initial nod in generalized myasthenia gravis (gMG) in 2021 to a subcutaneous approval this summer—and now, a stellar showing in a second neuromuscular disease—Argenx’s flagship drug Vyvgar | From its initial nod in generalized myasthenia gravis (gMG) in 2021 to a subcutaneous approval this summer—and now, a stellar showing in a second neuromuscular disease—Argenx’s flagship drug Vyvgart is proving its merit as a potential pipeline product.
Pharma Marketing Network
JULY 17, 2023
Amy Turnquist has more than 20 years of experience leading teams to create and deliver innovative, client-centric solutions that connect pharmaceutical brands with their HCP and consumer audiences. In her role as a Principal at North Highland, Amy helps healthcare organizations transform their engagement strategy, driving sustainable change and measurable impact by keeping people at the heart of every decision.
Copyright Clearance Center
JULY 19, 2023
Together, this panel reflected on successful collaborations that streamline OA processes, remove unnecessary work for the researchers, and enable cross-stakeholder transparency.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
MedCity News
JULY 17, 2023
As of January 1, employer-sponsored Group Health Plans and Health Insurance Issuers must make make the prices of 500 medical services available via an Internet-based tool. The Transparency in Coverage final rule gets even tougher on January 1, 2024, when the prices of all medical services must be made available via an Internet-based tool.
Fierce Pharma
JULY 17, 2023
Apellis Pharmaceuticals' Syfovre, after achieving the first FDA approval for advanced eye disease geographic atrophy, has been associated with rare but severe side effects, according to the America | The American Society of Retinal Specialists sent out a note to doctors on Saturday warning of eye inflammation cases in patients who took Syfovre, including six reports of occlusive retinal vasculitis.
Pharma Marketing Network
JULY 19, 2023
Sponsorships can be a powerful tool for pharmaceutical companies to engage with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But with so many different healthcare organizations and causes to choose from, it can be difficult to know where to start. Here are some tips for choosing the right sponsorships for maximum impact in the pharmaceutical industry: Start with your goals: What do you hope to achieve through your sponsorship?
PharmExec
JULY 17, 2023
In this Q&A, Craig Serra, head of commercial solutions and partnerships within the clinical research business unit at Flatiron Health (affiliate of the Roche Group), shares his perspective on clinical research, the role of data, and Flatiron Health’s efforts to that end.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
MedCity News
JULY 16, 2023
KFF found that the 10 top-selling Part D drugs represented $47.7 billion of the $215.7 billion total gross Medicare Part D drug spending in 2021. Eliquis, a blood thinner by Bristol Myers Squibb, accounted for the most spending out of these 10 drugs at $12.6 billion.
Fierce Pharma
JULY 20, 2023
Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. | Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. Its latest move follows a separate $400 million pledge to build a plant in the country.
Pharma Marketing Network
JULY 19, 2023
The pharmaceutical industry is constantly evolving, and digital technology is playing an increasingly important role in marketing campaigns. In the past, pharmaceutical companies relied heavily on traditional marketing methods such as print ads, TV commercials, and direct mail. However, these methods are becoming less effective as consumers are increasingly turning to digital channels for information and research.
European Pharmaceutical Review
JULY 21, 2023
Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
JULY 20, 2023
We may not fully understand the link between Covid-19 and Alzheimer’s, but we already have the scientific research and tools to address people’s fears, support their cognitive health journey, and reverse the increase of Alzheimer’s.
Fierce Pharma
JULY 20, 2023
After a recent study of Eisai's subcutaneous Leqembi formulation, the company is touting its "promising" results. | Eisai showed off "promising" results from a modeling and bioavailability study of its subcutaneous Leqembi formulation. Astellas joined the growing list of drugmakers taking on the Inflation Reduction Act with legal action.
PharmaTech
JULY 18, 2023
Jeff Fischer, co-founder and president of Longhorn Vaccines and Diagnostics, discusses the history and ongoing development of both protein- and mRNA-based vaccines.
European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97 billion by 2030.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
MedCity News
JULY 17, 2023
AstraZeneca and Sanofi drug Beyfortus is now FDA approved for preventing respiratory problems from RSV infection in infants and toddlers. Antibody engineering enables the drug to last longer in the body, providing protective effects for potentially the entire RSV season.
Fierce Pharma
JULY 21, 2023
If at first you don’t succeed, try, try again. That’s the lesson Daiichi Sankyo likely took home Friday after scoring a long-awaited U.S. | Some four years after Daiichi Sankyo's quizartinib scored its initial green light in Japan—and suffered a slap-down from drug regulators stateside—the acute myeloid leukemia medicine has won the FDA’s blessing.
PharmExec
JULY 18, 2023
An insightful discussion about how Meta's newest social media platform, Threads, is quickly adding another facet to the digital landscape for pharma marketers.
European Pharmaceutical Review
JULY 21, 2023
A semi-quantitative limulus amebocyte lysate (LAL) gel clot test with a narrow dilution range can be valuable for relatively accurate estimation of endotoxin in biopharmaceutical products, research shows. The paper published in Vaccine Research demonstrated the compatibility and benefits of LAL gel clot tests in a semi-quantitative manner compared to the LAL chromogenic assay.
Advertiser: ZoomInfo
In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.
Expert insights. Personalized for you.
246 
Let's personalize your content